Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
Andriani Charpidou (Athens, Greece). Overview of irAEs. ERS Skills course: Multi-disciplinary care in thoracic oncology

Member's Comments

No comment yet.

Related content which might interest you: Predictors of immunotherapy induced immune-related adverse events Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019 Late Breaking Abstract - Cardiovascular adverse events of drugs targeting IL-5 in severe asthma: a pharmacovigilance study Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Management of disease- and therapy-related adverse events Source: ERS Online Course 2019: Essentials of modern lung cancer care – catch up with the latest advances Year: 2019 Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Adverse anti-tuberculosis drug events and their management Source: Eur Respir Monogr 2018; 82: 205-227 Year: 2018 Late Breaking Abstract - Promising results of the infliximab biosimilar Inflectra® in severe sarcoidosis patients Source: International Congress 2017 – The many faces of sarcoidosis Year: 2017 Late Breaking Abstract - Response to mepolizumab in patients with severe CRSwNP using EUFOREA 2021 criteria Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Immune-Related Adverse Events Associated with Immune Checkpoint Blockade in Lung Cancer – A restrospective study. Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection Year: 2020 Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Reported outcomes in patients referred with persisting respiratory symptoms following non-hospitalised COVID-19 Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021 Late Breaking Abstract - Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE) Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 How to manage immune-related adverse effects in lung cancer patients under immunotherapy Source: CME Online 2019 Year: 2018 Late Breaking Abstract - Characterizing responders to benralizumab for severe asthma: pooled analysis of the SIROCCO and CALIMA studies Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations) Source: Eur Respir J 2007; 30: Suppl. 51, 125s Year: 2007 The IMPACT Trial: Single Inhaler Triple Therapy vs dual therapies: Consistent benefit across multiple exacerbation endpoints Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Combination immunotherapy in mesothelioma: managing expectations and new toxicities Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Early Clinically Important Improvement (ECII) and exacerbation outcomes in the FLAME study Source: International Congress 2018 – Clinical trials in COPD: new results Year: 2018 Early events in the development of allergic inflammation Source: Annual Congress 2006 - PG4 - Asthma: pathology and treatment Year: 2006